All Immuno Content

Bringing you the latest research in immuno-oncology, autoimmunity, therapeutic modalities and more, through a range of Speaker Interviews, Industry Insights, and Expert Opinions.

Insight Article
Early and effective treatment of cancers could mean the difference between life and death. Therefore, companion diagnostics and biomarker discovery could be considered one of the most important avenues to explore in immuno-oncology.
By Tom Cohen |
07 April 2022
Biomarkers in Immuno-Oncology
Insight Article
What is the future of precision medicine for immuno-oncology, and how can we achieve it? In this Insight Article, we sat down with senior representatives from the University of Michigan, the Beth Israel Deaconess Medical Center / Harvard Medical School, and The Institute of Cancer Research, London, to discover more about harnessing the potential of spatial biology and predictive biomarkers to achieve targeted results.
By Tia Byer |
12 January 2022
Biomarkers in Immuno-Oncology
Commentary
At the 2021 Immuno Week: Online event, we sat down with an advisory board comprised of key figures from some of the top biotech companies and research institutions to discuss the acute need for improved combination therapies and predictive biomarkers in immuno-oncology.
By Tia Byer |
22 September 2021
Biomarkers in Immuno-Oncology
Commentary
Patient-specific medicine in Immunotherapy and Immuno-oncology is fast becoming a globally recognised form of cancer treatment. But how easy is it to apply AI and ML to tailor a treatment for each individual patient? Director of Genomic Immuno-Oncology at Evaxion Biotech, Jens Kringelum, investigates how best to integrate data generation and ML to decode the immune system.
By Tia Byer |
16 September 2021
Biomarkers in Immuno-Oncology
Written Q&A
Peter H Schafer, Executive Director, Translational Development, Celgene
20 February 2020
Biomarkers in Immuno-Oncology
Written Q&A
Zhongwu Lai, Principal Scientist, Cancer Informatics, AstraZeneca
08 October 2019
Biomarkers in Immuno-Oncology
Written Q&A
Andrea Murray, Chief Operational Scientist, Oncimmune Ltd.
21 February 2019
Biomarkers in Immuno-Oncology
Post-Event Report
Statistics, Delegate & Solution Provider Testimonials,
11 October 2018
Biomarkers in Immuno-Oncology
Written Q&A
Geert Mudde, Chief Scientific Officer, OncoQR ML GmbH
24 May 2018
Biomarkers in Immuno-Oncology

Search by Keyword

Filter by Subject Area

Filter by Content Type

We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.

Contact Us:

Copyright Oxford Global Marketing Limited. All rights reserved.

Member Community Login